Clinical Trial Update: A PET Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PET imaging study in healthy volunteers has completed, evaluating an investigational compound related to depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• GlaxoSmithKline investigational compound

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED